Professor Golo Ahlenstiel

Professor Golo Ahlenstiel

Chair, Medicine, Blacktown,
School of Medicine

Biography

After completing his doctoral degree in immunogenetics at the University of Bonn, Germany, Golo Ahlenstiel received research fellowship awards from the National Institutes of Health (NIH, USA) and from the German Research Foundation (DFG, Germany) to work in the Rehermann laboratory at the NIH on the immunopathogenesis of chronic liver disease, in particular the role of innate immunity in HCV infection. Golo moved to Australia in 2009 to undertake basic physician and advanced training in Gastroenterology and Hepatology, before he became staff Specialist and Conjoint Associate Professor with University of Sydney in 2014. In 2017 Golo Ahlenstiel was appointed Chair of Medicine at Blacktown Mount Druitt Hospitals with Western Sydney of University.

As Professor of Medicine Golo Ahlenstiel now heads the Blacktown Clinical Research Unit (https://www.westernsydney.edu.au/bmdcs_rc), and the Liver research program at Blacktown Hospital & Clinical School. Further, he chairs the newly established bariatric research program that studies all aspects of obesity-related health issues as well as using basic science approaches to understand its pathogenesis. This will allow us to develop new personalized health interventions for our patients.

Golo Ahlenstiel also heads the Immunology Group at Storr Liver Centre at the Westmead Institute for Medical Research (https://www.westmeadinstitute.org.au/research/research-divisions/liver-and-metabolic/liver-immunology-group/overview) with a focus on innate immunity in liver and gut as well as drivers of inflammation in chronic liver and gastrointestinal disease. Golo Ahlenstiel is currently also a Clinical Academic in Gastroenterology & Hepatology at Blacktown Hospital.

This information has been contributed by Professor Ahlenstiel.

Qualifications

  • MD Bonn - Beuel

Professional Memberships

  • Gastroenterological Society of Australia (GESA) (2012)
  • European Association for the Study of the Liver (EASL) (2012)
  • American Association for the Study of the Liver (AASLD) (2004)
  • Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS; German Gastroenterological Association) (2002)
  • Deutsche Gesellschaft für Innere Medizin (DGIM; German Association of Internal Medicine) (2002)
  • Australian Liver Association (ALA) (2017)

Awards

  • Westmead Institute Scientific Excellence (WISE) award 2016-12-08
  • Westmead Institute Scientific Excellence (WISE) award 2018-12-06
  • Consultant of the year, Westmead RMO Association 2016-11-04

Interests

  • Chronic inflammation
  • Gastroenterology
  • Hepatology
  • Immunology
  • Innate immunity
  • Liver disease
  • Obesity

Organisational Unit (School / Division)

  • School of Medicine

Committees

  • WSLHD Quality and Safety Council
  • Obesity Research Program, Blacktown Hospital
  • SPHERE Triple I Strategic Advisory Committee
  • Faculty, The Westmead Institute for Medical Research
  • Westmead Research Hub

Contact

Email: G.Ahlenstiel@westernsydney.edu.au
Phone: (02) 9851 6073
Mobile:
Location: OFF
Off Campus
Website:

PLEASE NOTE: obtaining information from this Directory must be for the legitimate purposes of doing business with and within Western Sydney University, and must not be used for unsolicited bulk e-mailing (spamming) or similar purposes.

Publications

Chapters in Books

  • Ahlenstiel, G. and Rehermann, B. (2007), 'Hepatic NK, NKT, and T Cells', Liver Immunology: Principles and Practice, Humana Press 9781588298188.

Journal Articles

  • Kreuter, R., Wankell, M., Ahlenstiel, G. and Hebbard, L. (2019), 'The role of obesity in inflammatory bowel disease', Biochimica et Biophysica Acta. Molecular Basis of Disease, vol 1865, no 1 , pp 63 - 72.
  • Read, S., Obeid, S., Ahlenstiel, C. and Ahlenstiel, G. (2019), '[In Press] The role of zinc in antiviral immunity', Advances in Nutrition, .
  • Eslam, M., Ahlenstiel, G. and George, J. (2019), '[In Press] Interferon lambda and liver fibrosis', Journal of Interferon and Cytokine Research, .
  • Shek, D., Read, S., Ahlenstiel, G. and Piatkov, I. (2019), 'Pharmacogenetics of anticancer monoclonal antibodies', Cancer Drug Resistance, vol 2 , pp 69 - 81.
  • Wijaya, R., Read, S., Schibeci, S., Eslam, M., Azardaryany, M., El-Khobar, K., Van der Poorten, D., Lin, R., Yuen, L., Lam, V., George, J., Douglas, M. and Ahlenstiel, G. (2019), 'KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B', Journal of Hepatology, vol 71, no 2 , pp 252 - 264.
  • Gupta, S., Read, S., Shackel, N., Hebbard, L., George, J. and Ahlenstiel, G. (2019), 'The role of micronutrients in the infection and subsequent response to hepatitis C virus', Cells, vol 8, no 6 .
  • Read, S., Parnell, G., Booth, D., Douglas, M., George, J. and Ahlenstiel, G. (2018), 'The antiviral role of zinc and metallothioneins in hepatitis C infection', Journal of Viral Hepatitis, vol 25, no 5 , pp 491 - 501.
  • Van Der Poorten, D., McLeod, D., Ahlenstiel, G., Read, S., Kwok, A., Santhakumar, C., Bassan, M., Culican, S., Campbell, D., Wong, S., Evans, L., Jideh, B., Kane, A., Katelaris, C., Keat, K., Ko, Y., Lee, J., Limaye, S., Lin, M. and Berglund, L. (2018), 'Gastric cancer screening in common variable immunodeficiency', Journal of Clinical Immunology, vol 38, no 7 , pp 768 - 777.
  • Read, S., O'Connor, K., Suppiah, V., Ahlenstiel, C., Obeid, S., Cook, K., Cunningham, A., Douglas, M., Hogg, P., Booth, D., George, J. and Ahlenstiel, G. (2017), 'Zinc is a potent and specific inhibitor of IFN-3 signalling', Nature Communications, vol 8 .
  • Desomer, L., Tate, D., Awadie, H., Pillay, L., Ahlenstiel, G. and Bourke, M. (2017), 'Persistent pain after colonic endoscopic mucosal resection : predictors, a management algorithm and outcomes', Gastrointestinal Endoscopy, vol 85, no 5S , pp 421 - 421.
  • Obeid, S., Wankell, M., Charrez, B., Sternberg, J., Kreuter, R., Esmaili, S., Ramezani-Moghadam, M., Devine, C., Read, S., Bhathal, P., Lopata, A., Ahlenstiel, G., Qiao, L., George, J. and Hebbard, L. (2017), 'Adiponectin confers protection from acute colitis and restricts a B cell immune response', Journal of Biological Chemistry, vol 292, no 16 , pp 6569 - 6582.
  • Klein, A., Ahlenstiel, G., Tate, D., Burgess, N., Richardson, A., Pang, T., Byth, K. and Bourke, M. (2017), 'Endoscopic resection of large duodenal and papillary lateral spreading lesions is clinically and economically advantageous compared with surgery', Endoscopy, vol 49, no 7 , pp 659 - 667.
  • Mah, X., Gupta, V., Loch, S., Ahlenstiel, G. and Van Der Poorten, D. (2017), 'Compounded levofloxacin triple therapy is safe and effective for refractory Helicobacter pylori', International Journal of Pharmaceutical Compounding, vol 21, no 4 , pp 330 - 333.
  • Klein, A., Gizbar, M., Bourke, M. and Ahlenstiel, G. (2016), 'Validated computed cleansing score for video capsule endoscopy', Digestive Endoscopy, vol 28, no 5 , pp 564 - 569.
  • Eslam, M., Hashem, A., Romero-Gomez, M., Berg, T., Dore, G., Mangia, A., Chan, H., Irving, W., Sheridan, D., Abate, M., Adams, L., Weltman, M., Bugianesi, E., Spengler, U., Shaker, O., Fischer, J., Mollison, L., Cheng, W., Ahlenstiel, G. and George, J. (2016), 'FibroGENE : a gene-based model for staging liver fibrosis', Journal of Hepatology, vol 64, no 2 , pp 390 - 398.
  • O'Connor, K., Read, S., Wang, M., Schibeci, S., Eslam, M., Ong, A., Weltman, M., Douglas, M., Mazzola, A., Craxi, A., Petta, S., Stewart, G., Liddle, C., George, J., Ahlenstiel, G. and Booth, D. (2016), 'IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection', Genes and Immunity, vol 17, no 6 , pp 328 - 334.
  • Read, S., Ramezani-Moghadam, M., Schibeci, S., George, J. and Ahlenstiel, G. (2016), 'Interferon lambda drives a pro-inflammatory phenotype in macrophages', European Journal of Immunology, vol 46, no Suppl. 1 , pp 438 - 438.
  • Pellise, M., Burgess, N., Bahin, F., Ahlenstiel, G., Sonson, R., Williams, S., Lee, E., McLeod, D., Mahajan, H. and Bourke, M. (2015), 'Extended wide field endoscopic mucosal resection does not reduce recurrence compared to standard endoscopic mucosal resection of large colonic laterally spreading lesions', Gastrointestinal Endoscopy, vol 81, no 5S , pp 168 - 169.
  • Garcia, M., Ahlenstiel, G., Mahajan, H. and Van Der Poorten, D. (2015), 'Small bowel varices secondary to chronic superior mesenteric vein thrombosis in a patient with heterozygous Factor V Leiden mutation : a case report', Journal of Medical Case Reports, vol 9, no 1 .
  • Musumba, C., Hsu, C., Ahlenstiel, G., Tutticci, N., Nanda, K., Van Der Poorten, D., Lee, E. and Kwan, V. (2015), 'Feasibility and safety of overtubes for PEG-tube placement in patients with head and neck cancer', Gastroenterology Research and Practice, vol 2015 .
  • Dold, L., Ahlenstiel, G., Althausen, E., Luda, C., Schwarze-Zander, C., Boesecke, C., Wasmuth, J., Rockstroh, J. and Spengler, U. (2015), 'Survival and HLA-B*57 in HIV/HCV co-infected patients on highly active antiretroviral therapy (HAART)', PLoS One, vol 10, no 8 .
  • Eslam, M., Hashem, A., Leung, R., Romero-Gomez, M., Berg, T., Dore, G., Chan, H., Irving, W., Sheridan, D., Abate, M., Adams, L., Mangia, A., Weltman, M., Bugianesi, E., Spengler, U., Shaker, O., Fischer, J., Mollison, L., Ahlenstiel, G. and Ahlenstiel, G. (2015), 'Interferon-rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease', Nature Communications, vol 6 .
  • Beard, M., Ffrench, R., Gowans, E., Helbig, K., Eyre, N., Douglas, M., Grebely, J., Ahlenstiel, G., Locarnini, S., George, J., Shackel, N., White, P., Thompson, A. and Drummer, H. (2014), 'A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses', Gastroenterology, vol 147, no 1 , pp 1 - 4.
  • O'Connor, K., Parnell, G., Patrick, E., Ahlenstiel, G., Suppiah, V., Van Der Poorten, D., Read, S., Leung, R., Douglas, M., Yang, Y., Stewart, G., Liddle, C., George, J. and Booth, D. (2014), 'Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent', Genes and Immunity, vol 15, no 2 , pp 88 - 94.
  • Musumba, C., Hsu, C., Ahlenstiel, G., Tutticci, N., Nanda, K., Van Der Poorten, D., Lee, E. and Kwan, V. (2014), 'Safety and efficacy of overtubes for preventing cutaneous metastasis during PEG tube placement in patients with head and neck cancer : a single-center study', Gastrointestinal Endoscopy, vol 79, no 5S , pp 280 - 280.
  • Rotman, Y., Noureddin, M., Feld, J., Guedj, J., Witthaus, M., Han, H., Park, Y., Park, S., Heller, T., Ghany, M., Doo, E., Koh, C., Abdalla, A., Gara, N., Sarkar, S., Thomas, E., Ahlenstiel, G., Edlich, B., Titerence, R. and Liang, T. (2014), 'Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C', Gut, vol 63, no 1 , pp 161 - 169.
  • O'Connor, K., George, J., Booth, D. and Ahlenstiel, G. (2014), 'Dendritic cells in hepatitis C virus infection : key players in the IFNL3-genotype response', World Journal of Gastroenterology, vol 20, no 47 , pp 17830 - 17838.
  • O'Connor, K., Ahlenstiel, G., Suppiah, V., Schibeci, S., Ong, A., Leung, R., Van Der Poorten, D., Douglas, M., Weltman, M., Stewart, G., Liddle, C., George, J. and Booth, D. (2014), 'IFNL3 mediates interaction between innate immune cells : implications for hepatitis C virus pathogenesis', Innate Immunity, vol 20, no 6 , pp 598 - 605.
  • Eslam, M., Leung, R., Romero-Gomez, M., Mangia, A., Irving, W., Sheridan, D., Spengler, U., Mollison, L., Cheng, W., Bugianesi, E., McLeod, D., Zaitoun, A., Attino, V., Goeltz, D., Nattermann, J., Douglas, M., Booth, D., George, J. and Ahlenstiel, G. (2014), 'IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection', Journal of Hepatology, vol 61, no 2 , pp 235 - 241.
  • Ahlenstiel, G., Hourigan, L., Brown, G., Zanati, S., Williams, S., Singh, R., Moss, A., Sonson, R. and Bourke, M. (2014), 'Actual endoscopic versus predicted surgical mortality for treatment of advanced mucosal neoplasia of the colon', Gastrointestinal Endoscopy, vol 80, no 4 , pp 668 - 676.
  • O'Day, R., Ahlenstiel, G., Shetty, A., Favaloro, E., Williams, S. and Koutts, J. (2014), 'Artefactual "in-vitro coagulopathy" in a patient with non-Hodgkin lymphoma and lower gastrointestinal bleeding', Medical Journal of Australia, vol 200, no 5 , pp 293 - 294.
  • Werner, J., Serti, E., Chepa-Lotrea, X., Stoltzfus, J., Ahlenstiel, G., Noureddin, M., Feld, J., Liang, T., Rotman, Y. and Rehermann, B. (2014), 'Ribavirin improves the IFN-Y response of natural killer cells to IFN-based therapy of hepatitis C virus infection', Hepatology, vol 60, no 4 , pp 1160 - 1169.
  • Eslam, M., Booth, D., George, J. and Ahlenstiel, G. (2013), 'Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection', World Journal of Gastroenterology, vol 19, no 41 , pp 7055 - 7061.
  • Ahlenstiel, G. (2013), 'The natural killer cell response to HCV infection', Immune Network, vol 13, no 5 , pp 168 - 176.
  • Ahlenstiel, G., Sonson, R. and Bourke, M. (2013), 'Diagnosis and treatment of radiation proctitis', Video Journal and Encyclopedia of GI Endoscopy, vol 1, no 2 , pp 316 - 317.
  • O'Day, R., Gillies, M. and Ahlenstiel, G. (2013), 'Ophthalmologic complications of antiviral therapy in hepatitis C treatment', World Journal of Gastroenterology, vol 19, no 45 , pp 8227 - 8237.
  • Suppiah, V., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Irving, W., Powell, E., Nattermann, J., Mueller, T., Riordan, S., Stewart, G., George, J., Booth, D. and Ahlenstiel, G. (2013), 'CCR5-32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection', Genes and Immunity, vol 14, no 5 , pp 286 - 290.
  • Booth, D., Ahlenstiel, G. and George, J. (2012), 'Pharmacogenomics of hepatitis C infections : personalizing therapy', Genome Medicine, vol 4, no 12 .
  • Ahlenstiel, G., Booth, D. and George, J. (2012), 'Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?', Antiviral Therapy, vol 17 , pp 1163 - 1170.
  • Edlich, B., Ahlenstiel, G., Azpiroz, A., Stoltzfus, J., Noureddin, M., Serti, E., Feld, J., Liang, J., Rotman, Y. and Rehermann, B. (2012), 'Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients', Hepatology, vol 55, no 1 , pp 39 - 48.
  • Ahlenstiel, G., Booth, D. and George, J. (2011), 'Clinical significance of IL28B gene variation in hepatitis C virus infection', Hot Topics in Viral Hepatitis, vol 7, no 20 , pp 17 - 24.
  • Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Irving, W., Powell, E., Hellard, M., Riordan, S., Mathews, G., Sheridan, D., Nattermann, J., Smedile, A., Ahlenstiel, G. and Booth, D. (2011), 'IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort : a cross-sectional study', PLoS Medicine, vol 8, no 9 .
  • Ahlenstiel, G., Edlich, B., Hogdal, L., Rotman, Y., Noureddin, M., Feld, J., Holz, L., Titerence, R., Liang, T. and Rehermann, B. (2011), 'Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C', Gastroenterology, vol 141, no 4 , pp 1231 - 1239.
  • Feld, J., Modi, A., El?Diwany, R., Rotman, Y., Thomas, E., Ahlenstiel, G., Titerence, R., Koh, C., Cherepanov, V., Heller, T., Ghany, M., Park, Y., Hoofnagle, J. and Liang, T. (2011), 'S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders', Gastroenterology, vol 140, no 3 , pp 830 - 839.
  • Smith, K., Suppiah, V., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Matthews, G., Irving, W., Powell, E., Riordan, S., Ahlenstiel, G., Stewart, G., Bahlo, M., George, J. and Booth, D. (2011), 'Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort', Genome Medicine, vol 3 .
  • Ahlenstiel, G., Bourke, M., Moss, A., Williams, S., Hourigan, L., Brown, G., Singh, R., Tam, W. and Chen, R. (2010), 'Actual endoscopic vs predicted surgical mortality for the treatment of large (> 20 Mm) laterally spreading tumors (LSTS) and sessile lesions of the colon : outcomes from a large, prospective multicenter trial', Gastroenterology, vol 138, no 5 , pp 635 - 636.
  • Ahlenstiel, G., Booth, D. and George, J. (2010), 'IL28B in hepatitis C virus infection : translating pharmacogenomics into clinical practice', Journal of Gastroenterology, vol 45, no 9 , pp 903 - 910.
  • Vogel, M., Ahlenstiel, G., Hintsche, B., Fenske, S., Trein, A., Lutz, T., Schurmann, D., Stephan, C., Khaykin, P., Bickel, M., Mayr, C., Baumgarten, A., Buggisch, P., Klinker, H., John, C., Golz, J., Staszewski, S. and Rockstroh, J. (2010), 'The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals', European Journal of Medical Research, vol 15, no 3 , pp 102 - 111.
  • Ahlenstiel, G., Titerence, R., Koh, C., Edlich, B., Feld, J., Rotman, Y., Ghany, M., Hoofnagle, J., Liang, T., Heller, T. and Rehermann, B. (2010), 'Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner', Gastroenterology, vol 138, no 1 , pp 325 - 335.
  • Yoon, J., Shiina, M., Ahlenstiel, G. and Rehermann, B. (2009), 'Natural killer cell function is intact after direct exposure to infectious hepatitis C virions', Hepatology, vol 49, no 1 , pp 12 - 21.
  • Ahlenstiel, G., Woitas, R., Iwan, A., Nattermann, J., Feldmann, G., Rockstroh, J., Oldenburg, J., Kupfer, B., Sauerbruch, T. and Spengler, U. (2009), 'Effects of the CCR5-delta 32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia', Immunological Investigations, vol 38, no 1 , pp 284 - 296.
  • Mas Marques, A., Mueller, T., Welke, J., Taube, S., Sarrazin, C., Wiese, M., Halangk, J., Witt, H., Ahlenstiel, G., Spengler, U., Goebel, U., Schott, E., Weich, V., Schlosser, B., Wasmuth, H., Lammert, F., Berg, T. and Schreier, E. (2009), 'Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection', Infection, Genetics and Evolution, vol 9, no 5 , pp 847 - 852.
  • Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M., Bassendine, M., Spengler, U., Dore, G., Powell, E., Riordan, S., Smedile, A., Fragomeli, V., Muller, T., Bahlo, M., Stewart, G., Booth, D. and George, J. (2009), 'IL28B is associated with response to chronic hepatitis C interferon-a and ribavirin therapy', Nature Genetics, vol 41, no 10 , pp 1100 - 1104.
  • Nattermann, J., Vogel, M., Nischalke, H., Danta, M., Ahlenstiel, G., Michalk, M., Sauerbruch, T., Rockstroh, J. and Spengler, U. (2008), 'The TGF-? high producer genotype is associated with response to HCV-specific therapy in HIV-positive patients with acute hepatitis C', Journal of Hepatology, vol 48 , pp 305 - 306.
  • Caggiari, L., De Zorzi, M., Ahlenstiel, G., Rehermann, B. and De Re, V. (2008), 'Identification of new major histocompatibility complex-A, -B, -C alleles in chimpanzees (Pan troglodytes)', Tissue Antigens, vol 72, no 1 , pp 79 - 83.
  • Nattermann, J., Vogel, M., Nischalke, H., Danta, M., Ahlenstiel, G., Michalk, M., Sauerbruch, T., Rockstroh, J. and Spengler, U. (2008), 'The transforming growth factor-? high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C', AIDS, vol 22, no 11 , pp 1287 - 1292.
  • Mix, H., Weiler-Normann, C., Thimme, R., Ahlenstiel, G., Shin, E., Herkel, J., David, C., Lohse, A. and Rehermann, B. (2008), 'Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis', Gastroenterology, vol 135, no 6 , pp 2107 - 2118.
  • De Zorzi, M., Caggiari, L., Ahlenstiel, G., Rehermann, B. and De Re, V. (2008), 'Description of two new major histocompatibility complex (MHC) class II DRB1 [Pan troglodytes (Patr)-DRB1] alleles', Tissue Antigens, vol 71, no 5 , pp 490 - 492.
  • Ahlenstiel, G., Martin, M., Gao, X., Carrington, M. and Rehermann, B. (2008), 'Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses', Journal of Clinical Investigation, vol 118, no 3 , pp 1017 - 1026.
  • Ahlenstiel, G., Nischalke, H., Bueren, K., Berg, T., Vogel, M., Biermer, M., Grunhage, F., Sauerbruch, T., Rockstroh, J., Spengler, U. and Nattermann, J. (2007), 'The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients', Journal of Hepatology, vol 47, no 3 , pp 348 - 355.

Media

Title: Australian Researchers Investigate Zinc as Potential Ally Against Liver Disease
Description: Media publication on our research
Title: Health workers in Western Sydney are set for the recognition they deserve at the Quality Awards
Description: Clinical projects
Title: Zinc may hold key to fighting liver disease
Description: Media publication on our research

Western Sydney University

Locked Bag 1797
Penrith NSW 2751

Tel: +61 2 9852 5222

ABN 53 014 069 881
CRICOS Provider No: 00917k

Visit our mobile site